# International AIDS Vaccine Initiative

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/international-aids-vaccine-initiative/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 91.8 |
| Citations | 529,518 |
| City | New York |
| Country | US |
| Description | International AIDS Vaccine Initiative is a research organisation in New York, US. OpenAlex records 1,795 works and 529,518 citations for it. 516 researchers list it as their most recent affiliation. |
| Homepage | https://www.iavi.org/ |
| OpenAlex ID | https://openalex.org/I1310987316 |
| Researchers | 516 |
| ROR ID | https://ror.org/05ayv2203 |
| Type | funder |
| Wikidata ID | https://www.wikidata.org/wiki/Q17003871 |
| Works | 1,795 |

## University papers

Showing 12 of 14.

- [Dynamics of HIV-1 recombination in its natural target cells](https://scholariq.org/papers/dynamics-of-hiv-1-recombination-in-its-natural-target-cells/)
- [Virologic and Immunologic Determinants of Heterosexual Transmission of Human Immunodeficiency Virus Type 1 in Africa](https://scholariq.org/papers/virologic-and-immunologic-determinants-of-heterosexual-transmission-of-human/)
- [Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study](https://scholariq.org/papers/prognostic-value-of-interferon-release-assays-and-tuberculin-skin-test-in/)
- [Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways](https://scholariq.org/papers/escape-from-autologous-neutralizing-antibodies-in-acute-early-subtype-c-hiv-1/)
- [Ghrelin Induces Abdominal Obesity Via GHS-R-Dependent Lipid Retention](https://scholariq.org/papers/ghrelin-induces-abdominal-obesity-via-ghs-r-dependent-lipid-retention/)
- [Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania](https://scholariq.org/papers/safety-and-immunogenicity-of-a-2-dose-heterologous-vaccination-regimen-with-ad26/)
- [Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials](https://scholariq.org/papers/efficacy-and-immunogenicity-of-a-single-dose-of-human-papillomavirus-vaccine/)
- [Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial](https://scholariq.org/papers/immunogenicity-and-safety-of-one-dose-human-papillomavirus-vaccine-compared-with/)
- [T-Cell Immunophenotyping Distinguishes Active From Latent Tuberculosis](https://scholariq.org/papers/t-cell-immunophenotyping-distinguishes-active-from-latent-tuberculosis/)
- [Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study](https://scholariq.org/papers/clinical-utility-of-existing-and-second-generation-interferon-release-assays-for/)
- [IGRAs – The gateway to T cell based TB diagnosis](https://scholariq.org/papers/igras-the-gateway-to-t-cell-based-tb-diagnosis/)
- [Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial](https://scholariq.org/papers/comparing-one-dose-of-hpv-vaccine-in-girls-aged-9-14-years-in-tanzania-doris/)

## University researchers

- [Hilary Whitworth](https://scholariq.org/researchers/hilary-whitworth/)

## University top topics

Showing 8 of 25.

- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)
- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [vaccines and immunoinformatics approaches](https://scholariq.org/topics/vaccines-and-immunoinformatics-approaches/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.